Description:

GOG-0218 Cycle Dose Drug Form Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer NCT00262847 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F11B7C47-A6FE-54E9-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=F11B7C47-A6FE-54E9-E034-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/8/15
  3. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Cycle Dose Drug Form Fallopian Tube Cancer (NCT00262847)

No Instruction available.

  1. StudyEvent: GOG-0218 Cycle Dose Drug Form
    1. No Instruction available.
Header Module
Treatment Cycle And Modification
Cycle delayed
Cycle delayed reason
Were there any dose modifications or additions/omissions to protocol treatment (1=Yes, planned 2 =Yes, unplanned 3=No)
Kg
Performance status (Zubrod)
Pretreatment Hematology And Chemistry Values
g/dL
1000/uL
1000/uL
1000/uL
mg/dL
mg/dL

Similar models